Prodrugs are described whose structures have a oligopeptide chain which is substituted by a nucleophilic chemotherapeutic residue at the .alpha.-position. The products have increased cell membrane permeability and beneficial physico-chemical properties.
描述了结构中含有寡肽链的前药,该链在α位点被亲核化疗残基取代。这些产物具有增加的细胞膜渗透性和有益的物理
化学性质。